Prosecution Insights
Last updated: April 19, 2026

Examiner: SABOUR, GHAZAL

Tech Center 1600 • Art Units: 1672 1686

This examiner grants 29% of resolved cases

Performance Statistics

29.0%
Allow Rate
-31.0% vs TC avg
65
Total Applications
+32.3%
Interview Lift
1246
Avg Prosecution Days
Based on 31 resolved cases, 2023–2026

Rejection Statute Breakdown

33.2%
§101 Eligibility
10.6%
§102 Novelty
33.4%
§103 Obviousness
14.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17817457 PERFORMANCE REPORTS ASSOCIATED WITH CONTINUOUS SENSOR DATA FROM MULTIPLE ANALYSIS TIME PERIODS Final Rejection Dexcom, Inc.
17236998 METHODS AND SYSTEMS FOR ANALYSIS OF RECEPTOR INTERACTION Non-Final OA REGENERON PHARMACEUTICALS, INC.
19210931 CANCER TREATMENT EFFICACY EVALUATION UPON UNDERGOING OR COMPLETING A CANCER TREATMENT Non-Final OA Tempus AI, Inc.
17475271 MACHINE LEARNING ANALYSIS FOR METABOLOMICS CLASSIFICATION AND BIOMARKER DISCOVERY Final Rejection THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
17772451 SYSTEMS AND METHODS FOR NUCLEIC ACID SEQUENCING ASSEMBLY ASSOCIATED WITH IN SILICO GENOMIC VARIANT IDENTIFICATION Non-Final OA Foundation Medicine, Inc.
17288539 MACHINE LEARNING FOR PROTEIN IDENTIFICATION Non-Final OA TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
17154427 METHODS AND SYSTEMS FOR ADJUSTING A TRAINING GATE TO ACCOMMODATE FLOW CYTOMETER DATA Non-Final OA Becton, Dickinson and Company
17237958 System, Method and Computer Readable Medium to Estimate the Post-Treatment Blood Cell Sub Type Count in Patients Treated via Radiation Therapy Final Rejection University of Virginia Patent Foundation
17595185 CHEMICAL-DISEASE PERTURBATION RANKING Non-Final OA Northeastern University
17277518 HIGH THROUGHPUT METHOD AND SYSTEM FOR MAPPING INTRACELLULAR PHASE DIAGRAMS Final Rejection The Trustees of Princeton University
17333169 SYSTEMS AND METHODS FOR INSPIRATE SENSING TO DETERMINE A PROBABILITY OF AN EMERGENT PHYSIOLOGICAL STATE Non-Final OA GMECI, LLC
17759714 BIOMARKERS FOR DIAGNOSING OVARIAN CANCER Non-Final OA Venn Biosciences Corporation
17495571 METHOD AND SYSTEMS FOR PREDICTION OF HLA CLASS II-SPECIFIC EPITOPES AND CHARACTERIZATION OF CD4+ T CELLS Non-Final OA BioNTech US Inc.
17207541 Methods for Evaluation of Gestational Progress and Preterm Abortion for Clinical Intervention and Applications Thereof Non-Final OA Statens Serum Institut
17276675 MACHINE LEARNING FOR PROTEIN BINDING SITES Final Rejection BENEVOLENTAI TECHNOLOGY LIMITED
17299895 METHODS FOR MEASURING AND MONTORING A MEAT CHARACTERISTIC OF A LIVESTOCK ANIMAL FROM A SAMPLE OBTAINED FROM A NON-MEAT LOCATION OF THE LIVESTOCK Non-Final OA C Y O'CONNOR ERADE VILLAGE FOUNDATION INCORPORATED
17319986 METHODS OF IDENTIFYING GENETIC VARIANTS Final Rejection The Sydney Children's Hospitals Network (Randwick and Westmead)
16388614 METHOD AND SYSTEM FOR RAPID GENETIC ANALYSIS Non-Final OA RADY CHILDREN'S HOSPITAL RESEARCH CENTER

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month